{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T13:23:50Z","timestamp":1780320230717,"version":"3.54.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,28]]},"DOI":"10.7759\/cureus.55194","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T07:10:47Z","timestamp":1709190647000},"source":"Crossref","is-referenced-by-count":2,"title":["Antifungal Use in Perforated Peptic Ulcer Disease: A Western Australian Perspective"],"prefix":"10.7759","author":[{"given":"Nikitha","family":"Boyapati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidya","family":"Willis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32404-7","article-title":"Peptic ulcer disease","volume":"390","author":"Lanas A","year":"2017","unstructured":"Lanas A, Chan FK. Peptic ulcer disease. Lancet. 2017, 390:613-24. 10.1016\/S0140-6736(16)32404-7","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l5495","article-title":"Peptic ulcer disease","volume":"367","author":"Sverd\u00e9n E","year":"2019","unstructured":"Sverd\u00e9n E, Agr\u00e9us L, Dunn JM, Lagergren J. Peptic ulcer disease. BMJ. 2019, 367:l5495. 10.1136\/bmj.l5495","journal-title":"BMJ"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.03960.x","article-title":"Systematic review: the global incidence and prevalence of peptic ulcer disease","volume":"29","author":"Sung JJ","year":"2009","unstructured":"Sung JJ, Kuipers EJ, El-Serag HB. Systematic review: the global incidence and prevalence of peptic ulcer disease. Aliment Pharmacol Ther. 2009, 29:938-46. 10.1111\/j.1365-2036.2009.03960.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1089\/sur.2019.024","article-title":"Fungal isolates in peritoneal fluid culture do not impact peri-operative outcomes of peptic ulcer perforation","volume":"20","author":"Kwan JR","year":"2019","unstructured":"Kwan JR, Lim M, Ng F, Shelat V. Fungal isolates in peritoneal fluid culture do not impact peri-operative outcomes of peptic ulcer perforation. Surg Infect (Larchmt). 2019, 20:619-24. 10.1089\/sur.2019.024","journal-title":"Surg Infect (Larchmt)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00276-7","article-title":"Perforated peptic ulcer","volume":"386","author":"S\u00f8reide K","year":"2015","unstructured":"S\u00f8reide K, Thorsen K, Harrison EM, Bingener J, M\u00f8ller MH, Ohene-Yeboah M, S\u00f8reide JA. Perforated peptic ulcer. Lancet. 2015, 386:1288-98. 10.1016\/S0140-6736(15)00276-7","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s13017-019-0283-9","article-title":"Perforated and bleeding peptic ulcer: WSES guidelines","volume":"15","author":"Tarasconi A","year":"2020","unstructured":"Tarasconi A, Coccolini F, Biffl WL, et al.. Perforated and bleeding peptic ulcer: WSES guidelines. World J Emerg Surg. 2020, 15:3. 10.1186\/s13017-019-0283-9","journal-title":"World J Emerg Surg"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1089\/sur.2018.058","article-title":"Pre-operative anti-fungal therapy does not improve outcomes in perforated peptic ulcers","volume":"19","author":"Horn CB","year":"2018","unstructured":"Horn CB, Coleoglou Centeno AA, Rasane RK, et al.. Pre-operative anti-fungal therapy does not improve outcomes in perforated peptic ulcers. Surg Infect (Larchmt). 2018, 19:587-92. 10.1089\/sur.2018.058","journal-title":"Surg Infect (Larchmt)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1089\/sur.2021.286","article-title":"Role of empiric antifungal therapy in patients with perforated peptic ulcers","volume":"23","author":"Chammas M","year":"2022","unstructured":"Chammas M, Abdul Jawad K, Saberi RA, et al.. Role of empiric antifungal therapy in patients with perforated peptic ulcers. Surg Infect (Larchmt). 2022, 23:174-7. 10.1089\/sur.2021.286","journal-title":"Surg Infect (Larchmt)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1089\/sur.2019.062","article-title":"Role of empiric anti-fungal therapy in the treatment of perforated peptic ulcer disease: review of the evidence and future directions","volume":"20","author":"Huston JM","year":"2019","unstructured":"Huston JM, Kreiner L, Ho VP, Sanders JM, Duane TM. Role of empiric anti-fungal therapy in the treatment of perforated peptic ulcer disease: review of the evidence and future directions. Surg Infect (Larchmt). 2019, 20:593-600. 10.1089\/sur.2019.062","journal-title":"Surg Infect (Larchmt)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo D","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004, 240:205-13. 10.1097\/01.sla.0000133083.54934.ae","journal-title":"Ann Surg"},{"key":"ref11","article-title":"Proposed classification of complications of surgery with examples of utility in cholecystectomy","volume":"111","author":"Clavien PA","year":"1992","unstructured":"Clavien PA, Sanabria JR, Strasberg SM. Proposed classification of complications of surgery with examples of utility in cholecystectomy. Surgery. 1992, 111:518-26.","journal-title":"Surgery"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1089\/sur.2016.261","article-title":"The Surgical Infection Society revised guidelines on the management of intra-abdominal infection","volume":"18","author":"Mazuski JE","year":"2017","unstructured":"Mazuski JE, Tessier JM, May AK, et al.. The Surgical Infection Society revised guidelines on the management of intra-abdominal infection. Surg Infect (Larchmt). 2017, 18:1-76. 10.1089\/sur.2016.261","journal-title":"Surg Infect (Larchmt)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmm.2021.151490","article-title":"Fungi of the human gut microbiota: roles and significance","volume":"311","author":"P\u00e9rez JC","year":"2021","unstructured":"P\u00e9rez JC. Fungi of the human gut microbiota: roles and significance. Int J Med Microbiol. 2021, 311:151490. 10.1016\/j.ijmm.2021.151490","journal-title":"Int J Med Microbiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000202129.19154.64","article-title":"Candida in the peritoneum: passenger or pathogen?","volume":"34","author":"Rex JH","year":"2006","unstructured":"Rex JH. Candida in the peritoneum: passenger or pathogen?. Crit Care Med. 2006, 34:902-3. 10.1097\/01.CCM.0000202129.19154.64","journal-title":"Crit Care Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-015-3894-y","article-title":"Intra-abdominal candidiasis: it's still a long way to get unquestionable data","volume":"41","author":"Montravers P","year":"2015","unstructured":"Montravers P, Leroy O, Eckmann C. Intra-abdominal candidiasis: it's still a long way to get unquestionable data. Intensive Care Med. 2015, 41:1682-4. 10.1007\/s00134-015-3894-y","journal-title":"Intensive Care Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-011-1305-2","article-title":"Candida peritonitis: an update on the latest research and treatments","volume":"35","author":"Carneiro HA","year":"2011","unstructured":"Carneiro HA, Mavrakis A, Mylonakis E. Candida peritonitis: an update on the latest research and treatments. World J Surg. 2011, 35:2650-9. 10.1007\/s00268-011-1305-2","journal-title":"World J Surg"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-200203000-00008","article-title":"Significance of Candida recovered from intraoperative specimens in patients with intra-abdominal perforations","volume":"30","author":"Sandven P","year":"2002","unstructured":"Sandven P, Qvist H, Skovlund E, Giercksky KE. Significance of Candida recovered from intraoperative specimens in patients with intra-abdominal perforations. Crit Care Med. 2002, 30:541-7. 10.1097\/00003246-200203000-00008","journal-title":"Crit Care Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-015-3866-2","article-title":"A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality","volume":"41","author":"Bassetti M","year":"2015","unstructured":"Bassetti M, Righi E, Ansaldi F, et al.. A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality. Intensive Care Med. 2015, 41:1601-10. 10.1007\/s00134-015-3866-2","journal-title":"Intensive Care Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/tsaco-2020-000662","article-title":"Empiric antifungals do not decrease the risk for organ space infection in patients with perforated peptic ulcer","volume":"6","author":"Barmparas G","year":"2021","unstructured":"Barmparas G, Alhaj Saleh A, Huang R, et al.. Empiric antifungals do not decrease the risk for organ space infection in patients with perforated peptic ulcer. Trauma Surg Acute Care Open. 2021, 6:e000662. 10.1136\/tsaco-2020-000662","journal-title":"Trauma Surg Acute Care Open"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2015.07.004","article-title":"Antifungal therapy did not improve outcomes including 30-day all-cause mortality in patients suffering community-acquired perforated peptic ulcer-associated peritonitis with Candida species isolated from their peritoneal fluid","volume":"50","author":"Li WS","year":"2017","unstructured":"Li WS, Lee CH, Liu JW. Antifungal therapy did not improve outcomes including 30-day all-cause mortality in patients suffering community-acquired perforated peptic ulcer-associated peritonitis with Candida species isolated from their peritoneal fluid. J Microbiol Immunol Infect. 2017, 50:370-6. 10.1016\/j.jmii.2015.07.004","journal-title":"J Microbiol Immunol Infect"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-019-0702-9","article-title":"Antifungal resistance: a concerning trend for the present and future","volume":"21","author":"Hendrickson JA","year":"2019","unstructured":"Hendrickson JA, Hu C, Aitken SL, Beyda N. Antifungal resistance: a concerning trend for the present and future. Curr Infect Dis Rep. 2019, 21:47. 10.1007\/s11908-019-0702-9","journal-title":"Curr Infect Dis Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/233311-antifungal-use-in-perforated-peptic-ulcer-disease-a-western-australian-perspective","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T07:11:02Z","timestamp":1709190662000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/233311-antifungal-use-in-perforated-peptic-ulcer-disease-a-western-australian-perspective"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,28]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.55194","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,28]]}}}